SGB-3908

N/A

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameSGB-3908
Drug Alias NameSGB-3908IBI-3016IBI3016
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAngiotensinogen inhibitorsRNA interference
TargetsAngiotensinogen
Therapy Area/IndicationsMetabolic DiseasesEssential HypertensionHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSanegene Bio USA Inc
China Registration ClassN/A

Develop Information

Active CompaniesSanegene Bio USA IncSuzhou Sanegene Bio IncSanegeneBio Inc +[4] 
Inactive CompaniesN/A
Active IndicationsMetabolic DiseasesEssential HypertensionHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A